Second-line tenofovir alafenamide for children with HIV in Africa
View ORCID ProfileVictor Musiime, View ORCID ProfileAlexander J Szubert, View ORCID ProfileHilda A Mujuru, View ORCID ProfileCissy Kityo, Katja Doerholt, View ORCID ProfileShafic Makumbi, View ORCID ProfileVeronica Mulenga, Wedu Ndebele, Mwate Mwamabazi, View ORCID ProfileHelen McIlleron, Mutsa Bwakura-Dangarembizi, View ORCID ProfileEva Natukunda, Kyomuhendo Jovia Linda, Lara Monkiewicz, Monica Kapasa, Mary Nyathi, Bwendo Nduna, View ORCID ProfileAnnabelle South, Godfrey Musoro, Khozya Zyambo, View ORCID ProfileYingying Zhang, View ORCID ProfileSimon Walker, Anna Turkova, View ORCID ProfileA Sarah Walker, View ORCID ProfileAlasdair Bamford, View ORCID ProfileDiana M Gibb, CHAPAS-4 Trial Team
doi: https://doi.org/10.1101/2024.04.12.24304337
Victor Musiime
1Makerere University, College of Health Sciences, School of Medicine, Department of Paediatrics and Child Health, Kampala, Uganda
2Joint Clinical Research Centre, Kampala, Uganda
PhDAlexander J Szubert
3Medical Research Council Clinical Trials Unit at University College London, London, UK
MScHilda A Mujuru
4Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe
MMedCissy Kityo
2Joint Clinical Research Centre, Kampala, Uganda
PhdKatja Doerholt
3Medical Research Council Clinical Trials Unit at University College London, London, UK
MScShafic Makumbi
5Infectious Diseases Research Collaboration, Kampala, Uganda
MPHVeronica Mulenga
6University of Zambia, School of Medicine, Lusaka, Zambia
MScWedu Ndebele
7National University of Science and Technology (NUST), NUST Mpilo Hospital Complex, Bulawayo, Zimbabwe
MDMwate Mwamabazi
8Arthur Davison Children’s Hospital, Ndola, Zambia
MMedHelen McIlleron
9University of Cape Town, Cape Town, South Africa
PhDMutsa Bwakura-Dangarembizi
4Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe
10University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
PhDEva Natukunda
2Joint Clinical Research Centre, Kampala, Uganda
MMedKyomuhendo Jovia Linda
11Joint Clinical Research Centre, Lubowa, Uganda
MBChBLara Monkiewicz
3Medical Research Council Clinical Trials Unit at University College London, London, UK
MScMonica Kapasa
12University Teaching Hospitals Children’s Hospital, Zambia
MDMary Nyathi
13Mpilo Central Hospital, Bulawayo, Zimbabwe
MMedBwendo Nduna
10University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe
MMedAnnabelle South
3Medical Research Council Clinical Trials Unit at University College London, London, UK
PhDGodfrey Musoro
13Mpilo Central Hospital, Bulawayo, Zimbabwe
MScKhozya Zyambo
12University Teaching Hospitals Children’s Hospital, Zambia
MMedYingying Zhang
14Centre for Health Economics, University of York, York, England, UK
PhDSimon Walker
14Centre for Health Economics, University of York, York, England, UK
MScAnna Turkova
3Medical Research Council Clinical Trials Unit at University College London, London, UK
MDA Sarah Walker
3Medical Research Council Clinical Trials Unit at University College London, London, UK
PhDAlasdair Bamford
3Medical Research Council Clinical Trials Unit at University College London, London, UK
PhDDiana M Gibb
3Medical Research Council Clinical Trials Unit at University College London, London, UK
MScData Availability
MRC CTU at UCL supports a controlled access approach based on completion of a data request proforma available from the corresponding author (mrcctu.ucl.ac.uk/our-research/other-research-policy/data-sharing).
Posted April 21, 2024.
Second-line tenofovir alafenamide for children with HIV in Africa
Victor Musiime, Alexander J Szubert, Hilda A Mujuru, Cissy Kityo, Katja Doerholt, Shafic Makumbi, Veronica Mulenga, Wedu Ndebele, Mwate Mwamabazi, Helen McIlleron, Mutsa Bwakura-Dangarembizi, Eva Natukunda, Kyomuhendo Jovia Linda, Lara Monkiewicz, Monica Kapasa, Mary Nyathi, Bwendo Nduna, Annabelle South, Godfrey Musoro, Khozya Zyambo, Yingying Zhang, Simon Walker, Anna Turkova, A Sarah Walker, Alasdair Bamford, Diana M Gibb, CHAPAS-4 Trial Team
medRxiv 2024.04.12.24304337; doi: https://doi.org/10.1101/2024.04.12.24304337
Second-line tenofovir alafenamide for children with HIV in Africa
Victor Musiime, Alexander J Szubert, Hilda A Mujuru, Cissy Kityo, Katja Doerholt, Shafic Makumbi, Veronica Mulenga, Wedu Ndebele, Mwate Mwamabazi, Helen McIlleron, Mutsa Bwakura-Dangarembizi, Eva Natukunda, Kyomuhendo Jovia Linda, Lara Monkiewicz, Monica Kapasa, Mary Nyathi, Bwendo Nduna, Annabelle South, Godfrey Musoro, Khozya Zyambo, Yingying Zhang, Simon Walker, Anna Turkova, A Sarah Walker, Alasdair Bamford, Diana M Gibb, CHAPAS-4 Trial Team
medRxiv 2024.04.12.24304337; doi: https://doi.org/10.1101/2024.04.12.24304337
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (635)
- Anesthesia (169)
- Cardiovascular Medicine (2420)
- Dermatology (208)
- Emergency Medicine (382)
- Epidemiology (11843)
- Forensic Medicine (10)
- Gastroenterology (706)
- Genetic and Genomic Medicine (3802)
- Geriatric Medicine (353)
- Health Economics (642)
- Health Informatics (2433)
- Health Policy (944)
- Hematology (344)
- HIV/AIDS (798)
- Medical Education (373)
- Medical Ethics (105)
- Nephrology (404)
- Neurology (3553)
- Nursing (201)
- Nutrition (531)
- Oncology (1845)
- Ophthalmology (542)
- Orthopedics (224)
- Otolaryngology (289)
- Pain Medicine (234)
- Palliative Medicine (68)
- Pathology (452)
- Pediatrics (1047)
- Primary Care Research (425)
- Public and Global Health (6220)
- Radiology and Imaging (1304)
- Respiratory Medicine (840)
- Rheumatology (381)
- Sports Medicine (328)
- Surgery (409)
- Toxicology (51)
- Transplantation (174)
- Urology (148)